THE RESULTS: CVS Caremark Corp.'s fourth-quarter net income climbed nearly 4 percent. The company earned $1.06 billion, or 81 cents per share. Adjusted earnings were 89 cents per share, in line with the average analyst forecast.
Revenue rose 15 percent to $28.32 billion, beating expectations.
NEW FORECAST: The drugstore operator and pharmacy benefits manager raised its 2012 adjusted earnings guidance by 3 cents per share. It now expects $3.18 to $3.28 per share.
WHY: A contract squabble between competitor Walgreen Co. and Express Scripts Inc., a PBM, has driven more customers to CVS pharmacies.